QNTM - Quantum Biopharma Ltd.

6.36
-0.710   -11.164%

Share volume: 223,302
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$7.07
-0.71
-0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
-19.08%
1 Month
44.55%
3 Months
69.15%
6 Months
54.74%
1 Year
6,197.03%
2 Year
6,197.03%
Key data
Stock price
$6.36
P/E Ratio 
0.00
DAY RANGE
$5.96 - $7.05
EPS 
N/A
52 WEEK RANGE
$0.07 - $18.00
52 WEEK CHANGE
$6,197.03
MARKET CAP 
276.817 M
YIELD 
N/A
SHARES OUTSTANDING 
61.108 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
-2.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$367,432
AVERAGE 30 VOLUME 
$1,414,432
Company detail
CEO: Zeeshan Saeed
Region: US
Website: www.quantumbiopharma.com
Employees: 0
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.

Recent news
loading